Question
What will be the vaccine efficacy of the two-dose Johnson & Johnson Ad26.COV2.S vaccine candidate according to the results of Phase III testing?
Total Forecasters32
Community Prediction89.8 (82.6 - 94.5)
Make a Prediction
CDF
This question is closed for predictions, and is waiting to be resolved
My Prediction
communitylower 25%
median
upper 75%
...
...
...
82.61
89.82
94.5
Authors:
Opened:
Closed:
Scheduled resolution:
Comments
? comments
Authors:
Opened:
Closed:
Scheduled resolution: